机器学习使用磁共振成像识别帕金森病的各个阶段
1Faculty of Computer Science, Polish-Japanese Academy of Information Technology, 86 Koszykowa Street, 02-008 Warsaw, Poland.
Sensors (Basel, Switzerland)
|January 8, 2025
概括
分析脑部MRI扫描的机器学习模型可以识别帕金森病 (PD) 的早期阶段. 这项研究表明,结构性大脑分析准确地模拟了PD的进展,有助于早期诊断.
科学领域:
- 神经成像是一种神经成像.
- 机器学习 机器学习
- 神经学 神经学
背景情况:
- 像帕金森病 (PD) 这样的神经退行性疾病 (ND) 构成了日益严重的全球健康挑战.
- 早期发现PD对于实施有效的干预策略至关重要.
- 当前的诊断方法可能无法在早期阶段识别PD.
研究的目的:
- 研究从T1加权MRI扫描中对大脑区域进行结构分析的潜力,以建模PD阶段.
- 应用标准机器学习 (ML) 技术来区分健康对照组 (HC),生殖组 (PR) 和PD组.
- 评估使用皮质下大脑结构体积和空间关系用于PD分期的有效性.
主要方法:
- 从PPMI数据库 (N=168) 中使用T1加权的MRI扫描.
- 采用机器学习模型,包括后勤回归,随机森林,支持矢量分类器和粗集.
- 这些特征包括皮下结构相对于 thalamus 的体积和空间距离 (欧几里德式,共弦).
主要成果:
- 后勤回归在PD阶段识别中表现出高准确度 (85%),精度 (88%) 和回忆 (85%) 的最佳性能.
- 这些模型成功地区分了HC,PR和PD组.
- 像体积和以中心点为基础的空间距离等可解释的指标有助于高诊断准确度.
结论:
- 使用MRI和ML对大脑区域的结构分析为早期PD识别提供了一个有希望的框架.
- 开发的模型显示了非侵入性,准确的PD分期的巨大潜力.
- 这种方法可以促进及时干预并改善患者的治疗结果.
更多相关视频
相关概念视频
01:37Neural Regulation
34.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.7K
01:24Magnetic Resonance Imaging
7.6K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.6K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
26
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26